Related Experiment Video
Updated: Jan 1, 2026
Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
Published on: January 12, 2015
MiR-301a promotes embryonic stem cell differentiation to cardiomyocytes
Li-Xiao Zhen1, Yu-Ying Gu1, Qian Zhao1
1Key Laboratory of Arrhythmias of the Ministry of Education of China, Tongji University School of Medicine, Shanghai 200120, China.
Insights
MicroRNA-301a promotes the differentiation of mouse embryonic stem cells into cardiomyocytes. This finding offers potential for stem cell-based cardiac repair therapies, addressing challenges in treating heart disease.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Molecular Cardiology
Background:
- Cardiovascular disease is a leading global cause of mortality.
- Limited cardiomyocyte regeneration hinders cardiac tissue repair after injury.
- Stem cell-derived cardiomyocytes offer potential for heart repair therapies.
Purpose of the Study:
- To investigate the role of miR-301a in mouse embryonic stem cell (mES) differentiation into cardiomyocytes.
- To elucidate the underlying mechanisms of miR-301a in cardiac differentiation.
- To provide evidence for miR-301a's application in stem cell-based cardiac regeneration.
Main Methods:
- Overexpression of miR-301a in mES cells.
- Embryoid body formation using the hanging drop technique.
- Assessment of cardiomyocyte differentiation via cardiac marker expression (GATA-4, TBX5, MEF2C, α-actinin).
Main Results:
- miR-301a expression is high in developing mouse hearts.
- miR-301a overexpression significantly enhanced cardiac transcription factor expression and cardiomyocyte differentiation.
- miR-301a targets PTEN, influencing the PI3K-AKT-mTOR-Stat3 signaling pathway involved in differentiation.
Conclusions:
- miR-301a effectively promotes the differentiation of embryonic stem cells into cardiomyocytes.
- This microRNA represents a potential therapeutic target for cardiac regeneration.
Background:
Cardiovascular disease is the leading cause of death worldwide. Tissue repair after pathological injury in the heart remains a major challenge due to the limited regenerative ability of cardiomyocytes in adults. Stem cell-derived cardiomyocytes provide a promising source for the cell transplantation-based treatment of injured hearts.
Aim:
To explore the function and mechanisms of miR-301a in regulating cardiomyocyte differentiation of mouse embryonic stem (mES) cells, and provide experimental evidence for applying miR-301a to the cardiomyocyte differentiation induction from stem cells.
Methods:
mES cells with or without overexpression of miR-301a were applied for all functional assays. The hanging drop technique was applied to form embryoid bodies from mES cells. Cardiac markers including GATA-4, TBX5, MEF2C, and α-actinin were used to determine cardiomyocyte differentiation from mES cells.
Results:
High expression of miR-301a was detected in the heart from late embryonic to neonatal mice. Overexpression of miR-301a in mES cells significantly induced the expression of cardiac transcription factors, thereby promoting cardiomyocyte differentiation and beating cardiomyocyte clone formation. PTEN is a target gene of miR-301a in cardiomyocytes. PTEN-regulated PI3K-AKT-mTOR-Stat3 signaling showed involvement in regulating miR-301a-promoted cardiomyocyte differentiation from mES cells.
Conclusion:
MiR-301a is capable of promoting embryonic stem cell differentiation to cardiomyocytes.
More Related Videos
08:08Modified Mouse Embryonic Stem Cell based Assay for Quantifying Cardiogenic Induction Efficiency
Published on: April 22, 2011
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018